# RVMD PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/RVMD
Company: Revolution Medicines

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with RVMD.

## RVMD PDUFA Milestones

- 2026-08-26 — PDUFA — FDA approved RASONQUE for metastatic pancreatic adenocarcinoma. FDA approved once-daily oral RASONQUE for adults with metastatic pancreatic adenocarcinoma wh...
  Company: Revolution Medicines
  Source: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-daraxonrasib-metastatic-pancreatic-adenocarcinoma
  Event detail: https://biopharmsignal.com/pdufa-calendar/RVMD/daraxonrasib-metastatic-pancreatic-adenocarcinoma.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/august (August 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/RVMD
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the RVMD PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with RVMD, including decision dates, application stage, and summary details when available.
### Where can I find more context for RVMD?

Use the BioPharmSignal company page for RVMD to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.